Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis

Abstract Impending myasthenic crisis (IMC) is an emergent situation requiring aggressive management to prevent patients from developing myasthenic crisis (MC) in patients with myasthenia gravis (MG). Efgartigimod has been proved to be well tolerated and efficacious in MG patients. The present study...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Jing Ma, Huiqiu Zhang, Junsen Zhao, Menghan Su, Yingna Feng, Xiaoli Yuan, Dan Liu, Xiaomin Pang, Rongjuan Zhao, Juan Wang, Weisong Duan, Xueli Chang, Junhong Guo, Wei Zhang
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Portfolio 2024-11-01
Serija:	Scientific Reports
Teme:	Myasthenia gravis Impending myasthenic crisis Efgartigimod IVIg Efficacy
Online dostop:	https://doi.org/10.1038/s41598-024-79918-7
Oznake:	Označite Brez oznak, prvi označite!